Photopheresis Products Market Size & Share 2023 to 2032
Market Size by Product Type (Open System, Closed System), by Application (Graft Versus Host Disease, Cutaneous T-cell Lymphoma, Transplant Rejections, Autoimmune Diseases), by End Use (Hospitals.
Download Free PDF

Photopheresis Products Market Size
Photopheresis Products Market size was valued at over USD 270 million in 2022 and is projected to reach more than USD 440 million by 2032 due to growing incidence of cutaneous T-cell lymphoma.
Photopheresis Products Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Photopheresis products are used in a medical procedure known as extracorporeal photopheresis (ECP). This procedure involves the collection of a patient's blood, separation of specific components, treatment of those components with a photosensitizing agent, exposure of the treated components to ultraviolet (UV) light, and reinfusion of the treated blood components back into the patient. Photopheresis is primarily used for the treatment of certain blood disorders and immune-mediated conditions which are determined through performing various blood tests and other related tests.. For instance, multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system. It is estimated that there are approximately 2.8 million people suffering from with MS globally.
Moreover, increasing incidence of cutaneous T-cell lymphoma (CTCL) which is a rare form of non-Hodgkin lymphoma that predominantly impacts the skin. It is characterized by the abnormal proliferation of T lymphocytes in the skin. For instance, according to the Surveillance, Epidemiology, and End Results (SEER) data, the age-adjusted incidence rate of CTCL in the U.S. is estimated to be around 6.4 cases per million individuals per year.
COVID-19 Impact
The COVID-19 pandemic led to disruptions in healthcare services worldwide. Hospitals and healthcare facilities were overwhelmed with managing COVID-19 cases, resulting in a shift in resources and prioritization of care. Non-essential procedures and treatments, including photopheresis, were postponed or delayed, affecting the demand for photopheresis products. Moreover, the pandemic led to a significant focus on COVID-19 research, diverting resources and attention away from other areas of medical research, including photopheresis. This slowed down ongoing research and development efforts related to photopheresis products.
Photopheresis Products Market Trends
Increased government reimbursement policies and growing private healthcare insurance regarding photopheresis products are anticipated to stimulate market gains. Government reimbursement policies and expanded private healthcare insurance coverage can increase patient access to photopheresis treatment. By providing financial support, these policies make the treatment more affordable for patients, thereby increasing the demand for photopheresis products. This can lead to increased competition, innovation, and product development, benefiting healthcare providers and patients by providing a wider range of options and advancements in photopheresis technology.
Photopheresis Products Market Analysis
Based on product type, the photopheresis products market is segmented into closed system and open system. The closed system segment held the largest revenue size over USD 150 million in 2022 and is estimated to cross USD 240 million by 2032. Closed systems are designed to minimize the risk of contamination during the photopheresis procedure. With closed systems, the patient's blood or blood components remain contained within a closed circuit, reducing the exposure to external contaminants. This helps maintain the sterility and integrity of the blood sample, reducing the risk of infection or other complications.
Photopheresis products market is bifurcated based on the application including graft versus host disease (GVHD), autoimmune diseases, cutaneous T-cell lymphoma, and transplant rejections. The graft versus host disease segment is anticipated to grow over USD 170 million by 2032. GVHD is a common complication following allogeneic hematopoietic stem cell transplantation (HSCT), which involves the transplantation of stem cells from a donor to a recipient. The incidence and prevalence of GVHD in HSCT can vary depending on several factors, including the type of transplant, stem cell source (bone marrow, peripheral blood, or cord blood), conditioning regimen, and patient characteristics. It is estimated that acute GVHD occurs in 30% to 50% of allogeneic HSCT cases, while chronic GVHD occurs in approximately 40% to 60% of cases.
The photopheresis products market is segmented by end-use into hospitals, ambulatory surgical centres, and others. Hospitals segment accounting for more than 45% market share in 2022 and is estimated to witness over USD 200 million by 2032. Due to the widespread availability of innovative and affordable treatments, factors including the increase in testing and growing preference for treatment at hospitals will fuel market expansion. Hospitals also enable to offer early and precise disease diagnosis and patient treatment.
U.S. photopheresis products market accounted for more than USD 95 million in 2022 and will grow momentously more than USD 150 million by 2032. The affordability of photopheresis products among the target population base and ongoing technological developments are primarily responsible for the development of the regional business. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America industry. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in substantial number of product approvals and launches, particularly in the U.S.
Photopheresis Products Market Share
Some of the notable key photopheresis products market players operating in the photopheresis products industry include:
Photopheresis Products Industry News:
Photopheresis products market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product Type (USD Million)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →